Clinitech Laboratory Stock Screener | Share Price & Fundamental Analysis
CTLLAB
Healthcare Service Provider
Screen Clinitech Laboratory share price with our stock screener - analyze fundamentals and track trades in your journal
Market Cap
₹9.50 Cr.
P/B Ratio
1.07
EPS (TTM)
₹1.90
Dividend Yield
-
Debt to Equity
0.07
52W High
-
52W Low
-
Operating Margin
-
Profit Margin
-
EBITDA
-
Net Income
-
Total Assets
₹11.00
Total Equity
₹9.00
Clinitech Laboratory Share Price History - Stock Screener Chart
Screen CTLLAB historical share price movements with interactive charts. Analyze price trends and patterns.
Clinitech Laboratory Company Profile - Fundamental Screener
Screen Clinitech Laboratory company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CTLLAB shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE0QMR01015
Clinitech Laboratory Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen CTLLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 11 | 6 | 6 | 4 | 3 |
| Current Assets | 7 | 3 | 2 | 1 | 2 |
| Fixed Assets | 2 | 2 | 1 | 2 | 1 |
| Liabilities | |||||
| Total Liabilities | 11 | 6 | 6 | 4 | 3 |
| Current Liabilities | 0 | 0 | 2 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 9 | 4 | 2 | 2 | 1 |
| Share Capital | 2 | 2 | 2 | 2 | 1 |
| Reserves & Surplus | 7 | 2 | 1 | 0 | 1 |
Screen CTLLAB income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|
| Revenue | 0 | 9 | 6 | 6 | 7 | 5 |
| Expenses | 0 | 7 | 5 | 5 | 5 | 4 |
| EBITDA | 0 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | 0.00% | 10.00% | 16.00% | 21.00% | 17.00% | 18.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 1 | 1 | 1 | 1 | 1 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 1 | 1 | 0 |
| EPS | 0.00 | 1.90 | 2.37 | 4.09 | 3.42 | 6.04 |
Clinitech Laboratory Cash Flow Screener - Liquidity Fundamentals
Screen CTLLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|
| Operating Activities | -1 | -1 | 1 | 1 | 0 |
| Investing Activities | -1 | 1 | -1 | -2 | 1 |
| Financing Activities | 4 | 0 | 0 | 0 | -1 |
| Net Cash Flow | 2 | 0 | 1 | 0 | 0 |
Screen CTLLAB shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Sept | 2024-Jan | 2024-Jul | 2024-Sept |
|---|---|---|---|---|---|
| Promoter Holding | 61.58% | 62.42% | 83.63% | 61.58% | 61.58% |
| FII Holding | 0.32% | 0.32% | 0.00% | 0.32% | 0.32% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 36.28% | 35.91% | 0.00% | 33.81% | 35.91% |
| Other Holding | 1.83% | 1.36% | 16.37% | 4.30% | 2.20% |
| Shareholder Count | 303 | 303 | 24 | 450 | 346 |
Clinitech Laboratory Dividend Screener - Share Yield Analysis
Screen CTLLAB dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Clinitech Laboratory Index Membership - Market Screener Classification
Screen CTLLAB by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Clinitech Laboratory Market Events Screener - Corporate Actions
Screen CTLLAB market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -14.50% | ||
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | 4.76% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | 0.00% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -1.22% |
Clinitech Laboratory Competitors Screener - Peer Comparison
Screen CTLLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 24,700 | 46.83 | 2,555 | 11.28% | 492 | 51.43 |
| Vijaya Diagnostic Centre | 10,881 | 70.34 | 700 | 23.06% | 144 | 61.34 |
| Metropolis Healthcare | 10,019 | 61.96 | 1,346 | 10.64% | 146 | 53.04 |
| Thyrocare Technologies | 7,309 | 56.28 | 702 | 20.80% | 91 | 53.15 |
| Nephrocare Health Services | 4,760 | 68.04 | 770 | 33.97% | 67 | |
| Krsnaa Diagnostics | 2,379 | 28.37 | 743 | 16.70% | 78 | 46.09 |
| Suraksha Diagnostic | 1,441 | 45.66 | 256 | 15.11% | 31 | 45.86 |
| One Global Service Provider | 1,237 | 28.65 | 148 | 134.60% | 19 | 58.56 |
| 3B BlackBio DX | 1,214 | 24.67 | 112 | 28.72% | 48 | 56.43 |
| Sastasundar Ventures | 1,004 | -103.51 | 1,171 | -18.47% | -134 | 60.55 |
Clinitech Laboratory Company Announcements - News Screener
Screen CTLLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-19 | General Update W.R.T Incorporation Of Subsidiary Of The Company | View |
| 2025-11-22 | Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E Sturday November 22 2025 At 11.30 A.M | View |
| 2025-11-19 | Board Meeting Intimation for Board Meeting To Be Held On Saturday November 22 2025 At Its Registered Office At 11.30 A.M | View |
| 2025-11-17 | General Update W.R.T Memorandum Of Understanding ("MOU") Entered | View |
| 2025-11-12 | Statement Of Deviation & Variation As On September 30 2025 | View |
| 2025-11-12 | Financials Results For 30.09.2025 | View |
| 2025-11-12 | Board Meeting Outcome for Oucome Of Board Meeting Held Today Wednesday November 12 2025 | View |
| 2025-11-08 | Modified Intimation Of Board Meeting W.R.T Disclosure Of Trading Window Closure | View |
| 2025-11-07 | Board Meeting Intimation for 06Th Board Meeting To Be Held On Wednesday November 12 2025 Through Video Conferencing At 11.30 A.M | View |
| 2025-10-10 | Upgradation Of Existing Centre At Badlapur | View |
| 2025-10-10 | Non-Applicability Of Reg 23 Of SEBI (LODR) Regulations 2015 W.R.T Related Party Transaction | View |
| 2025-10-10 | Non-Applicability Of CG Report | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-27 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-09-24 | Closure of Trading Window | View |
| 2025-09-24 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-24 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-23 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-10 | Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements | View |
| 2025-08-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |